251
|
|
|
Semaphorin 6B |
EPM11, SEM-SEMA-Y, SEM-SEMA-Z, SEMA-VIB, SEMAN, semaZ |
|
252
|
|
|
Semaphorin 6C |
SEMAY, Sema-Y, m-SemaY, m-SemaY2 |
|
253
|
|
|
Semaphorin 6D |
- |
Alzheimer disease, Anorexia nervosa, Jeune syndrome, Attention deficit hyperactivity disorder, Autism, Behcet disease, Breast cancer, Cannabis abuse, Central nervous system cancer, Neurodevelopmental disorder, Crohn disease, Major depressive disorder, Eating disorder, Glioblastoma, Glioma, Hoarding disorder, Inflammatory bowel disease, Insomnia, Liver cirrhosis, Lung cancer, Metabolic syndrome, Neurotic disorder, Non-specific syndromic intellectual disability, Obsessive-compulsive disorder, Prostate cancer, Willis-ekbom disease, Schizophrenia, Scoliosis, Squamous cell carcinoma, Substance abuse, Diabetes mellitus type 2, Ulcerative colitisView all (17 more) |
254
|
|
|
Semaphorin 7A (JohnMiltonHagen blood group) |
CD108, CDw108, H-SEMA-K1, H-Sema-L, JMH, PFIC11, SEMAK1, SEMAL |
|
255
|
|
|
Semenogelin 1 |
CT103, SEMG, SGI, dJ172H20.2 |
|
256
|
|
|
Semenogelin 2 |
SGII |
|
257
|
|
|
SUMO specific peptidase 1 |
SuPr-2 |
Arteriosclerosis, Bipolar disorder, Coronary artery disease, Lung cancer, Major depressive disorder, Osteoarthritis, Primary graft dysfunction, Prostate cancer, Rheumatoid arthritis, Schizophrenia, Squamous cell carcinoma, Diabetes mellitus type 2, Vascular remodeling, Vasculitis |
258
|
|
|
SUMO specific peptidase 2 |
AXAM2, SMT3IP2 |
|
259
|
|
|
SUMO specific peptidase 3 |
SMT3IP1, SSP3, Ulp1 |
|
260
|
|
|
SUMO specific peptidase 5 |
- |
|